Zimmer upgraded to Buy from Neutral at Summer Street Summer Street upgraded Zimmer to Buy with a $133 price target citing the proposed acquisition of Biomet. The firm recommends using any weakness from the Q2 earnings report as a buying opportunity.
EU set to conditionally approve Zimmer, Biomet deal, Reuters reports The European Union is set to give conditional approval to Zimmer's proposed acquisition of Biomet, Reuters reports, citing two people with knowledge of the matter. Reference Link
Zimmer announces first clinical use of Vivacit-E liner Zimmer announced its first reverse shoulder replacement in the United States using Vivacit-E Liner for the Trabecular Metal Reverse Shoulder System.